Epidemiology of primary and secondary liver cancers.
暂无分享,去创建一个
[1] I. Purchase,et al. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. , 1985, British Journal of Cancer.
[2] N. Mcintyre,et al. Hepatocellular Carcinoma Arising in Non-Cirrhotic Haemochromatosis , 1995, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.
[3] Hai-rim Shin,et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. , 1996, International journal of epidemiology.
[4] P. Giral,et al. Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.
[5] A. Kuijsten,et al. Population-Attributable Risk of Dietary Aflatoxins and Hepatitis B Virus Infection with Respect to Hepatocellular Carcinoma , 2004, Nutrition and cancer.
[6] H. Tsukuma,et al. Case‐Control Study of Hepatocellular Carcinoma among Koreans Living in Osaka, Japan , 1994, Japanese journal of cancer research : Gann.
[7] S. Franceschi,et al. N‐Acetyltransferase‐2, glutathione S‐transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case‐control study , 2005, International journal of cancer.
[8] Hou Pao-Chang. The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. , 1956 .
[9] R. Hultcrantz,et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.
[10] S. Lee,et al. Turnover of biliary epithelial cells in Clonorchis sinensis infected rats. , 1993, The Korean journal of parasitology.
[11] K. Ishak,et al. HEPATIC ANGIOSARCOMA ASSOCIATED WITH ANDROGENIC-ANABOLIC STEROIDS , 1979, The Lancet.
[12] Shou-Dong Lee,et al. Are alcohol, tobacco and obesity genuine risk factors for hepatocellular carcinoma? , 2005, Journal of hepatology.
[13] D. Parkin,et al. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] M. Kew. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[15] H. Whittle,et al. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. , 2004, Pharmacogenetics.
[16] S. Hosoda,et al. Survey of thorotrast-associated liver cancers in Japan. , 1983, Journal of the National Cancer Institute.
[17] Chun-Ying Wu,et al. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? , 2002, Journal of gastroenterology and hepatology.
[18] M. Thun,et al. Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.
[19] Xiao Wang,et al. A case-control study of risk factors for hepatocellular carcinoma in Henan, China. , 1998, The American journal of tropical medicine and hygiene.
[20] C. Hellerbrand,et al. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[21] F. Farinati,et al. Hepatocellular carcinoma, alcohol, and cirrhosis: Facts and hypotheses , 1991, Digestive Diseases and Sciences.
[22] M. Tsutsumi,et al. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis. , 1996, Alcoholism, clinical and experimental research.
[23] W. Su,et al. A clinical study of 130 patients with biliary tract cancers and periampullary tumors. , 1996, Oncology.
[24] Chien-Jen Chen,et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. , 2003, American journal of epidemiology.
[25] R. A. Metcalf,et al. Mutational hot spot in the p53 gene in human hepatocellular carcinomas , 1991, Nature.
[26] A. Pezzoli,et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. , 1996, Journal of hepatology.
[27] A. Bergquist,et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case‐control study , 1998, Hepatology.
[28] V. Wiwanitkit,et al. The prevalence of hepatitis B seropositivity among patients with cholangiocarcinoma. , 2002, Viral immunology.
[29] Yuan‐Jen Wang,et al. Clinical experience in 126 patients with tissue‐proved proximal cholangiocarcinoma , 1994, Journal of gastroenterology and hepatology.
[30] P. Pineau,et al. Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases , 2000, Hepatology.
[31] C. Avellini,et al. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients , 2000, Cancer.
[32] A. Athanasiadou,et al. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study. , 1995, Journal of clinical gastroenterology.
[33] Josepa Ribes,et al. Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.
[34] C. Zhang,et al. Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. , 1991, Pharmacogenetics.
[35] I Mangelsdorf,et al. Vinyl chloride: still a cause for concern. , 2000, Environmental health perspectives.
[36] S. Porru,et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.
[37] A. Oshima,et al. Follow‐up study of hbs ag‐positive blood donors with special reference to effect of drinking and smoking on development of liver cancer , 1984, International journal of cancer.
[38] J. Crawford,et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. , 1988, Gastroenterology.
[39] K. Boberg,et al. Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.
[40] E. Molina,et al. Clinical Manifestations of Primary Hepatic Angiosarcoma , 2003, Digestive Diseases and Sciences.
[41] S. Thung,et al. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. , 2000, Chinese medical journal.
[42] S. Caldwell,et al. Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.
[43] C. Silver,et al. Incidence and Sites of Distant Metastases from Head and Neck Cancer , 2001, ORL.
[44] H. El‐Serag. Hepatocellular carcinoma: an epidemiologic view. , 2002, Journal of clinical gastroenterology.
[45] S. Horie,et al. c‐erbB‐2 protein is expressed in hepatolithiasis and cholangiocarcinoma , 1998, Histopathology.
[46] X. Wang,et al. Molecular pathogenesis of human hepatocellular carcinoma. , 2002, Toxicology.
[47] T. Hsiao,et al. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk , 2000, Gut.
[48] W. Tsai,et al. Polycyclic aromatic hydrocarbon‐DNA adducts in liver tissues of hepatocellular carcinoma patients and controls , 2002, International journal of cancer.
[49] K. McGlynn,et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.
[50] W. London,et al. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[51] A. Wald,et al. Hepatic angiosarcoma associated with short-term arsenic ingestion. , 1982, The American journal of medicine.
[52] Eugene R. Schiff,et al. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .
[53] Schwartz Da. Cholangiocarcinoma associated with liver fluke infection: a preventable source of morbidity in Asian immigrants. , 1986 .
[54] C. la Vecchia,et al. Risk factors for hepatocellular carcinoma in Northern Italy , 1988, International journal of cancer.
[55] N. Day,et al. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma , 1987, International journal of cancer.
[56] M. Gail,et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1 , 1999, Hepatology.
[57] King-Teh Lee,et al. Expression of Transforming Growth Factor Betas and Their Signaling Receptors in Stone-containing Intrahepatic Bile Ducts and Cholangiocarcinoma , 2003, World Journal of Surgery.
[58] C. J. Chen,et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. , 1997, American journal of epidemiology.
[59] G. Bunin. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. , 2004, Toxicology and applied pharmacology.
[60] J. Crowe,et al. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. , 1999, European journal of gastroenterology & hepatology.
[61] Masao Tanaka,et al. Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis. , 2002, Hepato-gastroenterology.
[62] S. Pauker,et al. Cost-effectiveness of Interferon-2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1995, Annals of Internal Medicine.
[63] S. Chiplunkar,et al. The detection of HBV antigens and HBx-transcripts in an Indian fibrolamellar carcinoma patient: a case study. , 2002, Liver.
[64] K. Ishak,et al. Epidemiology of hepatic angiosarcoma in the United States: 1964-1974. , 1981, Environmental health perspectives.
[65] M. Haswell-Elkins,et al. Cross‐sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high‐risk area in northeast thailand , 1994, International journal of cancer.
[66] B. Macmahon,et al. Smoking and hepatitis B-negative primary hepatocellular carcinoma. , 1980, Journal of the National Cancer Institute.
[67] A. Luciani,et al. Carcinome hépatocellulaire en l’absence de cirrhose au cours d’une stéato-hépatite non alcoolique , 2004 .
[68] J. Feusner,et al. Hepatoblastoma and low birth weight: a trend or chance observation? , 2002, Medical and pediatric oncology.
[69] M. Nakagawa,et al. Diabetes Mellitus May Be Associated with Hepatocarcinogenesis in Patients with Chronic Hepatitis C , 2002, Digestive Diseases and Sciences.
[70] J. Esteban,et al. Long interval between HCV infection and development of hepatocellular carcinoma. , 2008, Liver.
[71] A. Muñoz,et al. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[72] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[73] K. Lillemoe,et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.
[74] C. la Vecchia,et al. Attributable risks for hepatocellular carcinoma in northern Italy. , 1997, European journal of cancer.
[75] K. Chayama,et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.
[76] R O Morgan,et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.
[77] P. Boffetta,et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case‐control study in Italy , 1997 .
[78] C. Pairojkul,et al. Association of antibodies to Opisthorchis viverrini with hepatobiliary disease in northeastern Thailand. , 1994, The American journal of tropical medicine and hygiene.
[79] B. Werner,et al. Association of hepatitis b virus infection with hepatocellular carcinoma in american patients , 1980, International journal of cancer.
[80] A. Lonardo,et al. The wide spectrum of steatohepatitis: a report of four cases and a review of the literature , 2004, European journal of gastroenterology & hepatology.
[81] Jian-Min Yuan,et al. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. , 2004, Cancer.
[82] H. El‐Serag,et al. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans , 2001, American Journal of Gastroenterology.
[83] R. Chapman. Risk factors for biliary tract carcinogenesis. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[84] L. Abenhaim,et al. Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam , 1993, International journal of cancer.
[85] A. Ferraris,et al. Mutations of the HFE gene and the risk of hepatocellular carcinoma. , 1999, Blood cells, molecules & diseases.
[86] Y. Ko,et al. Survival and distribution pattern of childhood liver cancer in Taiwan. , 1998, European journal of cancer.
[87] S. Osada,et al. Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation , 2001, Journal of Gastroenterology.
[88] J. Reitsma,et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population , 2002, Gut.
[89] M. Hara,et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. , 2000, American journal of epidemiology.
[90] H. Adami,et al. Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.
[91] L. Covolo,et al. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. , 2003 .
[92] J. Goedert,et al. Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia. , 2000, Journal of the National Cancer Institute.
[93] S. Chevret,et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.
[94] J. Marrero,et al. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.
[95] A. Oshima,et al. A case‐control study of hepatocellular carcinoma in osaka, Japan , 1990, International journal of cancer.
[96] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[97] B. Henderson,et al. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. , 1989, Cancer research.
[98] Y. Hiraku,et al. Opisthorchis viverrini antigen induces the expression of Toll-like receptor 2 in macrophage RAW cell line. , 2005, International journal for parasitology.
[99] S. Sherlock,et al. Viruses and hepatocellular carcinoma. , 1994, Gut.
[100] K. Ishak,et al. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[101] B. Choi,et al. Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis , 2004, Clinical Microbiology Reviews.
[102] J. Hoofnagle,et al. NIH conference. Hepatocellular carcinoma. , 1988, Annals of internal medicine.
[103] H. Sriplung,et al. Histologic subtypes of hepatocellular carcinoma in the southern Thai population. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[104] K. Boberg,et al. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. , 2000, Journal of hepatology.
[105] H. Adami,et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma , 2000, International journal of cancer.
[106] N. Chalasani,et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case‐control study , 2000, Hepatology.
[107] S. Saab,et al. Fibrolamellar hepatocellular carcinoma , 1996, Digestive Diseases and Sciences.
[108] Teruaki Kimura,et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis , 2004, Journal of Gastroenterology.
[109] H. Pitt,et al. Choledochal Cyst Disease A Changing Pattern of Presentation , 1994, Annals of surgery.
[110] K. Ishak,et al. Arsenic-related hepatic angiosarcoma. , 1981, American journal of industrial medicine.
[111] T. Dharakul,et al. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[112] Chien-Jen Chen,et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan , 1996, International journal of cancer.
[113] V. Čulić,et al. Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer. , 2000, Environmental health perspectives.
[114] H. Hsu,et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. , 2000, JAMA.
[115] H. Adami,et al. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. , 2000, Journal of the National Cancer Institute.
[116] P. Pisani,et al. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.
[117] T. Hwang,et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis , 1993, Cancer.
[118] F. X. Bosch,et al. Risk factors for hepatocellular carcinoma in catalonia, spain , 1990, International journal of cancer.
[119] M. Taniai,et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH , 2004, Journal of Gastroenterology.
[120] R. Semba,et al. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. , 2004, Nitric oxide : biology and chemistry.
[121] O. Farges,et al. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries. , 2002, European journal of gastroenterology & hepatology.
[122] M. Cappellini,et al. Iron in the pathogenesis of hepatocellular carcinoma. , 1991, The Italian journal of gastroenterology.
[123] E. Schiff,et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.
[124] S. Hirohashi,et al. Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand. , 1991, Princess Takamatsu symposia.
[125] P. Toghill,et al. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. , 1988, Gut.
[126] A. Ekbom,et al. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. , 1997, Scandinavian journal of gastroenterology.
[127] K. Hasegawa,et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis. , 2004, Alcoholism, clinical and experimental research.
[128] P. Johnson,et al. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma , 1991, Cancer.
[129] D. V. van Thiel,et al. Mesenchymal tumors of the liver. , 2001, Clinics in liver disease.
[130] D. Gouma,et al. Choledochal cysts: age of presentation, symptoms, and late complications related to Todani's classification. , 2002, Journal of pediatric surgery.
[131] L. Rodrigo,et al. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. , 2002 .
[132] O. Yokosuka,et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients , 1995, Hepatology.
[133] K. Tolman,et al. Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus , 2004, Annals of Internal Medicine.
[134] K. Yamazaki,et al. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus. , 2001, Journal of submicroscopic cytology and pathology.
[135] E. Schiff,et al. A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.
[136] H. Margolis,et al. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States , 2000, Hepatology.
[137] K. Lindor,et al. Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.
[138] J. Crespo,et al. Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma , 2005, Obesity surgery.
[139] N. Leung,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.
[140] M. Mattioli,et al. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma. , 2001, Blood cells, molecules & diseases.
[141] G. Anagnostopoulos,et al. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis? , 2003, Journal of clinical gastroenterology.
[142] J. Fraumeni,et al. International trends and patterns of primary liver cancer , 2001, International journal of cancer.
[143] S. Banks,et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.
[144] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[145] S. Kubo,et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma , 2004, Cancer Science.
[146] M. Mattioli,et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease , 2001, Hepatology.
[147] V. P. Chacko,et al. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? , 2001, Cancer research.
[148] Manal M. Hassan,et al. Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United States , 2002, Journal of Clinical Gastroenterology.
[149] R. Colombari,et al. Hepatoblastoma in adult age: a report of two cases. , 1996, Hepato-gastroenterology.
[150] H. Tsukuma,et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.
[151] M. Feitelson. Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.
[152] A. Buda,et al. Increased Risk of Hepatocellular Carcinoma and Liver Cirrhosis in Vinyl Chloride Workers: Synergistic Effect of Occupational Exposure with Alcohol Intake , 2004, Environmental health perspectives.
[153] D. Lobo,et al. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. , 2004, Journal of hepatology.
[154] K. Boberg,et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis , 2002, Gut.
[155] K. Chayama,et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus , 1998, Cancer.
[156] H. El‐Serag,et al. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study , 2004, Hepatology.
[157] H. Ikeda,et al. Association between hepatoblastoma and very low birth weight: a trend or a chance? , 1997, The Journal of pediatrics.
[158] J. Samet,et al. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. , 2004, Journal of the National Cancer Institute.
[159] J. Ludwig,et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. , 2002, Journal of hepatology.
[160] S. Fan,et al. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. , 2004, Surgery.
[161] W. Stauffer,et al. Biliary liver flukes (Opisthorchiasis and Clonorchiasis) in immigrants in the United States: often subtle and diagnosed years after arrival. , 2004, Journal of travel medicine.
[162] J. Groopman. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment? , 1988, IARC scientific publications.
[163] M. Manns,et al. Target gene modulation in hepatocellular carcinomas by decreased DNA‐binding of p53 mutations , 1997, Hepatology.
[164] N. Ganne-Carrié,et al. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis , 2003, Gut.
[165] M. Alter,et al. Epidemiology of Hepatitis C , 2018, Clinical liver disease.
[166] F. Callea,et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.
[167] G. Loss,et al. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? , 2002, Hepatology.
[168] B. Henderson,et al. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. , 1982, Cancer research.
[169] C. J. Chen,et al. A case‐control study of primary hepatocellular carcinoma in Taiwan , 1988, Cancer.
[170] J. Mclaughlin,et al. Hepatic Angiosarcoma Occurring After Cyclophosphamide Therapy: Case Report and Review of the Literature , 2000, American journal of clinical oncology.
[171] P. Brissot,et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. , 1993, Gastroenterology.
[172] N. Kelekis,et al. Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature. , 2003, European journal of gastroenterology & hepatology.
[173] A. Bergquist,et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. , 2002, Journal of hepatology.
[174] Lu-Yu Hwang,et al. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.
[175] Y. Deugnier,et al. Iron and hepatocellular carcinoma , 2001, Journal of gastroenterology and hepatology.
[176] C. Oon. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions , 2004, Cancer Chemotherapy and Pharmacology.
[177] A. Suriawinata,et al. Liver Pathology in Obesity , 2004, Seminars in liver disease.
[178] Keitaro Tanaka,et al. Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, Japan , 1992, International journal of cancer.
[179] T. Nakashima,et al. Pathomorphologic characteristics of 102 cases of thorotrast‐related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma , 1988, Cancer.
[180] Akihiro Matsumoto,et al. Hepatocellular carcinoma: recent trends in Japan. , 2004, Gastroenterology.
[181] Yoshiyuki Suzuki,et al. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: Long‐term follow up of a pilot study , 2005, Journal of gastroenterology and hepatology.
[182] V. Siskind,et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. , 1985, Journal of the National Cancer Institute.
[183] K. Hess,et al. Unknown primary tumors metastatic to liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[184] K. Kowdley,et al. Hereditary hemochromatosis and cancer risk: more fuel to the fire? , 2001, Gastroenterology.
[185] C. Chen,et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma , 1996, Hepatology.
[186] Å. Danielsson,et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. , 1996, Gut.
[187] Z. Younossi,et al. Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C , 2004, Journal of clinical gastroenterology.
[188] H. El‐Serag,et al. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.
[189] D. Chan,et al. Hepatitis B and hepatitis C in emergency department patients. , 1992, The New England journal of medicine.
[190] J. Hoofnagle,et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. , 1991, The American journal of gastroenterology.
[191] R. Tamimi,et al. Risk factors for cholangiocarcinoma in a low risk Caucasian population , 2005, Sozial- und Präventivmedizin.
[192] E. Abdalla,et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[193] D. Parkin,et al. Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.
[194] J. Olsen,et al. Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark , 1995, International journal of cancer.
[195] Y. Ishikawa,et al. Microsatellite instability in thorotrast‐induced human intrahepatic cholangiocarcinoma , 2002, International journal of cancer.
[196] K. Tsuneyama,et al. Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis , 2001, Pathology international.
[197] C. Datz,et al. Mutations of the HFE gene in patients with hepatocellular carcinoma. , 2003 .
[198] Chien-Jen Chen,et al. Urinary aflatoxin levels, hepatitis‐b virus infection and hepatocellular carcinoma in taiwan , 1993, International journal of cancer.
[199] M. Matsuo. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study. , 2003, The Kurume medical journal.
[200] B. Henderson,et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.
[201] A. Tóth,et al. Prognosis of untreated liver metastasis from rectal cancer. , 1997, Acta chirurgica Hungarica.
[202] F. Callea,et al. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[203] D. Williams,et al. Occupationally related angiosarcoma of the liver in the United Kingdom 1972-1994. , 1996, Gut.
[204] S. Bloor,et al. Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus , 2001, Gut.
[205] G. Royle,et al. Breast Liver Metastases – Incidence, Diagnosis and Outcome , 1991, Journal of the Royal Society of Medicine.
[206] N. Tanaka,et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. , 1996, The American journal of gastroenterology.
[207] G. Sharp. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data. , 2002, Journal of radiation research.
[208] J. Marrero,et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. , 2005, Journal of hepatology.
[209] M. Sherman,et al. Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection , 2001, Hepatology.
[210] B. Henderson,et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. , 1991, Journal of the National Cancer Institute.
[211] K. Sugimachi,et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. , 2000, Journal of the American College of Surgeons.
[212] J. Gray,et al. Diabetes mellitus and primary hepatocellular carcinoma. , 1986, The Quarterly journal of medicine.